Skip to main content
Decorative image of the AMR Learning Lounge

Exploring Diagnostic and Antimicrobial Stewardship Interventions to Optimize Management of Gram-Negative Bacteremia

SUMMARY

In their proof-of-concept study, Dr. Claeys and colleagues compared three rapid diagnostic test panels using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy, or DOOR MAT, to diagnose Gram-negative bloodstream infections. “Through use of DOOR MAT, institutions can better determine which rapid diagnostic tests to implement based on local infectious diseases epidemiology and prescribing patterns.”

FEATURED EXPERTS

Kimberly Claeys, PharmD, BCPS, Associate Professor of Infectious Diseases at University of Maryland School of Pharmacy

J. Kristie Johnson, PhD, D(ABMM), Professor, Department of Pathology, and Medical Director, Microbiology, at University of Maryland Med

GET STARTED

Read the article at CAP Today.

Take me there now!

Read time: 7 minutes

Access the Webinar at CAP Today

Take me there now!

Watch time: 1 hour

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

Take Our Poll

Global solutions

BIOFIRE® Blood Culture Identification 2 Panel

The BIOFIRE BCID2 Panel tests for 43 targets associated with bloodstream infections, including Gram-negative bacteria, Gram-positive bacteria, yeast, and 10 antimicrobial resistance genes – all with one test and with results available in about an hour from positive blood culture.

Learn More
U.S. bioMérieux Solutions

US Solutions

BIOFIRE® Blood Culture Identification 2 Panel

The BIOFIRE BCID2 Panel tests for 43 targets associated with bloodstream infections, including Gram-negative bacteria, Gram-positive bacteria, yeast, and 10 antimicrobial resistance genes – all with one test and with results available in about an hour from positive blood culture.

Learn More

PUBLISHED BY

CAP Today Article and Webinar
April 1, 2022

SHARE THIS ARTICLE: